Related Experiment Videos
Transcription factor 1 and beta-cell function in glucose-tolerant subjects
1Division of Endocrinology, Diabetes, and Hypertension, Department of Medicine, University of California, Los Angeles School of Medicine, USA. kchiu@mednet.ucla.edu
Summary
The I27L polymorphism in the TCF1 gene significantly impacts beta-cell function, affecting both first and second phase insulin responses. This finding suggests a potential role for this genetic variation in the development of Type 2 diabetes.
Area of Science:
- Genetics and Molecular Biology
- Endocrinology and Metabolism
Background:
- Beta-cell dysfunction is a key factor in Type 2 diabetes pathogenesis.
- Transcription factor 1 (TCF1) mutations are known to impair beta-cell function.
Purpose of the Study:
- To investigate the effect of TCF1 gene amino acid polymorphisms on beta-cell function in glucose-tolerant Caucasians.
Main Methods:
- Hyperglycemic clamp technique used to measure insulin sensitivity index (ISI) and first/second phase insulin responses (1stIR, 2ndIR).
- Genotyping performed on genomic DNA to analyze TCF1 polymorphisms (I27L, A98V, S487N).
Main Results:
- The I27L polymorphism demonstrated a significant impact on both 1stIR (P=0.0052) and 2ndIR (P=0.0432).
- Multivariate analysis indicated I27L independently explained 12% of 1stIR variation and 6% of 2ndIR variation.
- I27L, along with ISI and age, accounted for 52% of the variation in 2ndIR.
Conclusions:
- The I27L polymorphism of TCF1 is an independent determinant of beta-cell function.
- This polymorphism may contribute to the pathogenesis of Type 2 diabetes.
- Further large-scale studies are needed to confirm genetic susceptibility to Type 2 diabetes.